Tuesday, Apr. 16, 2024

FEI Tribunal Announces Sanctions Against Rider, Owner And Veterinarian

The Federation Equestre Internationale has announced two new adverse analytical findings involving prohibited substances.

PUBLISHED
fei-logo_4.jpg

ADVERTISEMENT

The Federation Equestre Internationale has announced two new adverse analytical findings involving prohibited substances.

 Samples taken at the CSIO** in Tehran (Iran), Sept. 22-25 from the horse Sir de Diamant (FEI ID 102PH75/IRI), ridden by Iran’s Mohammad Davoud Shekofti, have returned positive for the banned substance stanozolol and its metabolite, 16 beta hydroxy-stanozol, an anabolic steroid that promotes muscle mass. The horse’s sample also tested positive for the controlled medication substances dexamethasone, a corticosteroid used to treat inflammatory and auto-immune conditions, and the non-steroidal anti-inflammatory drug flunixin.

Samples taken at the Young Horse Endurance Championships in Valeggio sul Minico (Italy) on Sept. 26 from the horse Barbaforte Bosana (FEI ID 104OJ42), ridden by Italy’s Camilla Malta, have tested positive for the banned substance ergonovine, a vasoconstrictor.

Both athletes have been provisionally suspended from the date of notification (Nov. 16). The horses have also been provisionally suspended for a two-month period.

In a separate case, the FEI has notified Dr. Pasha Syed Kamaal (India) that a case has been opened against him as support personnel in the 2012 case of Glenmorgan (FEI ID UAE40813). Samples taken from the horse, which was ridden by HH Sheik Hazza bin Sultan bin Zayed Al Nahyan (United Arab Emirates) in the CEI*** 160-kilometer at Al Wathba (UAE) on Feb. 10, 2012, returned positive for the banned substance propoxyphene, an opioid analgaesic, and its metabolite norpropoxyphene.

The FEI Tribunal had already imposed a 27-month suspension on HH Sheik Hazza bin Sultan bin Zayed Al Nahyan as the person responsible, which was reduced to 18 months on appeal to the Court of Arbitration for Sport. During the FEI Tribunal and CAS proceedings, Dr. Syed Kamaal made statements confirming that he had administered the product Fustex to the horse on the night before the event. Fustex contains propoxyphene, although it is not listed as an ingredient.

ADVERTISEMENT

Kamaal has been provisionally suspended from the date of notification (Nov. 16) in advance of the case coming before the FEI Tribunal.

Final Decisions

The FEI Tribunal has issued final decisions in the case of the horse Up Date 2 (FEI ID GER46325/ITA), with sanctions imposed against the rider, horse owner and vet. Samples taken from the horse at the CSI*** San Giovanni in Marignano, Italy, on Aug. 9 returned positive for the banned substance stanozol.

A two-year period of ineligibility was imposed on the rider, Mariano Ossa of Argentina, the person responsible under the FEI Equine Anti-Doping and Controlled Medication Regulations, from the date of sample collection. However, the FEI Tribunal reduced the period of suspension by five months as substantial assistance from the PR resulted in proceedings being opened against the horse owner and the vet. As a result, the PR will be ineligible through to March 8, 2016. He was also fined 2,000 swiss francs and ordered to pay 1,000 swiss francs towards the legal costs of the judicial procedure.

Additionally, the horse has been disqualified from all placings at the event, as well as from all placings achieved May 21, 2014, the date of administration of the banned substance.

The horse’s owner, Fabio Mazzarella of Venezuela, and the FEI Permitted Treating Veterinarian Dr. William Yerkes of the United States were both charged under Article 2.2 of the FEI Equine Anti-Doping Regulations relating to use or attempted use of a banned substance. A two-year period of ineligibility has been imposed on Dr. Yerkes, and a 19-month suspension for Mazzarella. Both periods of ineligibility have been backdated to May 21, 2014, the date when the banned substance was administered to the horse. The owner has also been fined 5,000 swiss francs. 

Categories:

ADVERTISEMENT

EXPLORE MORE

Follow us on

Sections

Copyright © 2024 The Chronicle of the Horse